These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22647883)

  • 1. Longitudinal progression of frontal and temporal lobe changes in schizophrenia.
    Cobia DJ; Smith MJ; Wang L; Csernansky JG
    Schizophr Res; 2012 Aug; 139(1-3):1-6. PubMed ID: 22647883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontal and temporal lobe brain volumes in schizophrenia. Relationship to symptoms and clinical subtype.
    Turetsky B; Cowell PE; Gur RC; Grossman RI; Shtasel DL; Gur RE
    Arch Gen Psychiatry; 1995 Dec; 52(12):1061-70. PubMed ID: 7492258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the frontotemporal cortex and cognitive correlates in first-episode psychosis.
    Gutiérrez-Galve L; Wheeler-Kingshott CA; Altmann DR; Price G; Chu EM; Leeson VC; Lobo A; Barker GJ; Barnes TR; Joyce EM; Ron MA
    Biol Psychiatry; 2010 Jul; 68(1):51-60. PubMed ID: 20452574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamically spreading frontal and cingulate deficits mapped in adolescents with schizophrenia.
    Vidal CN; Rapoport JL; Hayashi KM; Geaga JA; Sui Y; McLemore LE; Alaghband Y; Giedd JN; Gochman P; Blumenthal J; Gogtay N; Nicolson R; Toga AW; Thompson PM
    Arch Gen Psychiatry; 2006 Jan; 63(1):25-34. PubMed ID: 16389194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia.
    Spoletini I; Cherubini A; Di Paola M; Banfi G; Rüsch N; Martinotti G; Bria P; Rubino IA; Siracusano A; Caltagirone C; Spalletta G
    Schizophr Res; 2009 Mar; 108(1-3):57-68. PubMed ID: 19097861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting.
    Leung M; Cheung C; Yu K; Yip B; Sham P; Li Q; Chua S; McAlonan G
    Schizophr Bull; 2011 Jan; 37(1):199-211. PubMed ID: 19759093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric MRI assessment of temporal lobe structures in schizophrenia.
    Zipursky RB; Marsh L; Lim KO; DeMent S; Shear PK; Sullivan EV; Murphy GM; Csernansky JG; Pfefferbaum A
    Biol Psychiatry; 1994 Apr; 35(8):501-16. PubMed ID: 8038294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White matter alterations in schizophrenic patients with pronounced negative symptomatology and with positive family history for schizophrenia.
    Zetzsche T; Preuss UW; Frodl T; Leinsinger G; Born C; Reiser M; Hegerl U; Möller HJ; Meisenzahl EM
    Eur Arch Psychiatry Clin Neurosci; 2008 Aug; 258(5):278-84. PubMed ID: 18437282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
    Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
    Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural abnormalities in language circuits in genetic high-risk subjects and schizophrenia patients.
    Li X; Alapati V; Jackson C; Xia S; Bertisch HC; Branch CA; Delisi LE
    Psychiatry Res; 2012 Mar; 201(3):182-9. PubMed ID: 22512952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gray matter deficits, mismatch negativity, and outcomes in schizophrenia.
    Rasser PE; Schall U; Todd J; Michie PT; Ward PB; Johnston P; Helmbold K; Case V; Søyland A; Tooney PA; Thompson PM
    Schizophr Bull; 2011 Jan; 37(1):131-40. PubMed ID: 19561058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives].
    Semkovska M; Bédard MA; Stip E
    Encephale; 2001; 27(5):405-15. PubMed ID: 11760690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission status and cortical thickness in childhood-onset schizophrenia.
    Greenstein DK; Wolfe S; Gochman P; Rapoport JL; Gogtay N
    J Am Acad Child Adolesc Psychiatry; 2008 Oct; 47(10):1133-40. PubMed ID: 18724254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pronounced prefronto-temporal cortical thinning in schizophrenia: Neuroanatomical correlate of suicidal behavior?
    Besteher B; Wagner G; Koch K; Schachtzabel C; Reichenbach JR; Schlösser R; Sauer H; Schultz CC
    Schizophr Res; 2016 Oct; 176(2-3):151-157. PubMed ID: 27567290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive decrease of left superior temporal gyrus gray matter volume in patients with first-episode schizophrenia.
    Kasai K; Shenton ME; Salisbury DF; Hirayasu Y; Lee CU; Ciszewski AA; Yurgelun-Todd D; Kikinis R; Jolesz FA; McCarley RW
    Am J Psychiatry; 2003 Jan; 160(1):156-64. PubMed ID: 12505815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological impairments in deficit vs nondeficit forms of schizophrenia.
    Buchanan RW; Strauss ME; Kirkpatrick B; Holstein C; Breier A; Carpenter WT
    Arch Gen Psychiatry; 1994 Oct; 51(10):804-11. PubMed ID: 7944870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia.
    Zipparo L; Whitford TJ; Redoblado Hodge MA; Lucas S; Farrow TF; Brennan J; Gomes L; Williams LM; Harris AW
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):531-8. PubMed ID: 18061326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial and developmental abnormalities of front lobe function and neurochemistry in schizophrenia.
    Deakin FW; Simpson MD; Slater P; Hellewell JS
    J Psychopharmacol; 1997; 11(2):133-42. PubMed ID: 9254279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia.
    Whalley HC; Gountouna VE; Hall J; McIntosh A; Whyte MC; Simonotto E; Job DE; Owens DG; Johnstone EC; Lawrie SM
    BMC Psychiatry; 2007 Oct; 7():61. PubMed ID: 17967171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms.
    Sigmundsson T; Suckling J; Maier M; Williams S; Bullmore E; Greenwood K; Fukuda R; Ron M; Toone B
    Am J Psychiatry; 2001 Feb; 158(2):234-43. PubMed ID: 11156806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.